CBARX
Price
$47.85
Change
-$0.29 (-0.60%)
Updated
Aug 5 closing price
Net Assets
1.43B
RLBGX
Price
$37.00
Change
-$0.20 (-0.54%)
Updated
Aug 5 closing price
Net Assets
253.92B
Interact to see
Advertisement

CBARX vs RLBGX

Header iconCBARX vs RLBGX Comparison
Open Charts CBARX vs RLBGXBanner chart's image
Calvert Balanced R6
Price$47.85
Change-$0.29 (-0.60%)
VolumeN/A
Net Assets1.43B
American Funds American Balanced R6
Price$37.00
Change-$0.20 (-0.54%)
VolumeN/A
Net Assets253.92B
CBARX vs RLBGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CBARX vs. RLBGX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBARX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 254B vs. CBARX (1.43B). RLBGX pays higher dividends than CBARX: RLBGX (2.13) vs CBARX (1.53). CBARX was incepted earlier than RLBGX: CBARX (7 years) vs RLBGX (16 years). CBARX (0.61) is less costly to investors than RLBGX (0.25). CBARX is a more actively managed with annual turnover of: 153.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than CBARX: RLBGX (250) vs CBARX (5000000). CBARX annual gain was more profitable for investors over the last year : 11.97 vs. RLBGX (11.38). RLBGX (38.50) and CBARX (37.83) have equivalent 5 years return.
CBARXRLBGXCBARX / RLBGX
Total Expense Ratio0.610.25244%
Annual Report Gross Expense Ratio0.610.25244%
Fund Existence7 years16 years-
Gain YTD6.5628.55377%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.43B254B1%
Annual Yield % from dividends1.532.1372%
Returns for 1 year11.9711.38105%
Returns for 3 years35.0732.08109%
Returns for 5 years37.8338.5098%
Returns for 10 yearsN/A67.83-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KZIA8.680.34
+4.08%
Kazia Therapeutics Limited
CRESY11.430.25
+2.24%
Cresud S.A.C.I.F. y A.
UBXG2.930.02
+0.66%
U-BX Technology Ltd
L93.300.48
+0.52%
Loews Corp
FHB24.040.09
+0.38%
First Hawaiian